| Date Filed | Type | Description |
| 06/15/2023 |
4
| TZIANABOS ARTHUR (Director) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Granted 19,441 options to buy
@ $12.46, valued at
$242.2k
|
|
| 06/15/2023 |
4
| TZIANABOS ARTHUR (Director) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Granted 23,000 options to buy
@ $1.03, valued at
$23.7k
|
|
| 01/11/2023 |
4
| TZIANABOS ARTHUR (Director) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Sold 10,616 shares
@ $1.3905, valued at
$14.8k
|
|
| 01/04/2023 |
4
| TZIANABOS ARTHUR (Director) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Exercised 13,860 restricted stock units
@ $0
Exercised 19,140 restricted stock units
@ $0 |
|
| 12/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2022 |
4
| TZIANABOS ARTHUR (Director) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Granted 21,000 options to buy
@ $12.96, valued at
$272.2k
|
|
| 02/28/2022 |
4
| TZIANABOS ARTHUR (President & CEO) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Granted 350,000 options to buy
@ $2.71, valued at
$948.5k
Granted 58,000 restricted stock units
@ $0 |
|
| 01/12/2022 |
4
| TZIANABOS ARTHUR (President & CEO) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Sold 5,354 shares
@ $3.7802, valued at
$20.2k
Exercised 13,860 restricted stock units
@ $0 |
|
| 06/25/2021 |
4
| TZIANABOS ARTHUR (Director) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Granted 11,650 options to buy
@ $40.37, valued at
$470.3k
|
|
| 06/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2021 |
4
| TZIANABOS ARTHUR (Director) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Sold 10,000 shares
@ $60.6652, valued at
$606.7k
Exercised 10,000 options to buy
@ $2.19, valued at
$21.9k
|
|
| 02/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/25/2020 |
4
| TZIANABOS ARTHUR (Director) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Sold 4,300 shares
@ $45.0787, valued at
$193.8k
Sold 10,196 shares
@ $45.971, valued at
$468.7k
Sold 5,294 shares
@ $46.8472, valued at
$248k
Sold 210 shares
@ $47.6089, valued at
$10k
Exercised 20,000 options to buy
@ $2.19, valued at
$43.8k
|
|
| 06/25/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/05/2020 |
4
| TZIANABOS ARTHUR (Director) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Granted 14,777 options to buy
@ $26.53, valued at
$392k
|
|
| 02/05/2020 |
4
| TZIANABOS ARTHUR (President & CEO) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Sold 12,500 shares
@ $16.1617, valued at
$202k
|
|
| 01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/13/2019 |
4
| TZIANABOS ARTHUR (President & CEO) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Granted 358,000 options to buy
@ $19.92, valued at
$7.1M
|
|
| 12/03/2019 |
4
| TZIANABOS ARTHUR (President & CEO) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Sold 12,500 shares
@ $16.0447, valued at
$200.6k
Sold 12,500 shares
@ $16.2541, valued at
$203.2k
|
|
| 10/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/12/2019 |
4
| TZIANABOS ARTHUR (Director) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Granted 14,777 options to buy
@ $28.8, valued at
$425.6k
|
|
| 09/05/2019 |
4
| TZIANABOS ARTHUR (President & CEO) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Sold 12,500 shares
@ $18.7456, valued at
$234.3k
|
|
| 08/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2019 |
4
| TZIANABOS ARTHUR (President & CEO) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Sold 12,500 shares
@ $18.984, valued at
$237.3k
|
|
| 06/18/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/05/2019 |
4
| TZIANABOS ARTHUR (President & CEO) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Sold 12,500 shares
@ $19.861, valued at
$248.3k
|
|
| 12/18/2018 |
4
| TZIANABOS ARTHUR (President & CEO) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Granted 203,000 options to buy
@ $24.28, valued at
$4.9M
|
|
| 03/29/2018 |
4
| TZIANABOS ARTHUR (President & CEO) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Granted 92,376 options to buy
@ $16, valued at
$1.5M
|
|
| 03/27/2018 |
3
| TZIANABOS ARTHUR (President & CEO) has filed a Form 3 on Homology Medicines, Inc. |
| 08/30/2016 |
4
| TZIANABOS ARTHUR (Director) has filed a Form 4 on DNIB UNWIND, INC.|
Txns:
| Exercised 15,000 options to buy
@ $0.44, valued at
$6.6k
|
|
| 06/22/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/07/2015 |
4
| TZIANABOS ARTHUR (President and CSO) has filed a Form 4 on OvaScience, Inc.|
Txns:
| Granted 25,000 shares
@ $0 |
|
| 10/14/2015 |
4
| TZIANABOS ARTHUR (Director) has filed a Form 4 on BIND Therapeutics, Inc|
Txns:
| Granted 25,000 options to buy
@ $4.52, valued at
$113k
|
|
|